Are you a Quebec-based biopharmaceutical company? Don't miss this unique financing opportunity to propel your innovations in RNA therapies!
As part of AReNA, with the support of the MEIE, CQDM is launching a call for projects to support the development of cutting-edge technologies.
Objective : Accelerate the emergence of innovative RNA therapy processes, products and services - from proof of concept to pre-commercialization.
Who is the program for?
Aux Quebec startups, SMEs and large corporations in the field of biopharmaceutical technologies. Collaborations with other companies or research centers are encouraged.
Support offered :
- Up to 300 000 $ by project
- Maximum duration of 18 months
Dates to remember :
- Letter of intent : Before July 21, 2025 at 11:59 p.m.
- Complete file : Before August 4, 2025 at 11:59 PM
- Information webinar: the June 26, 2 p.m. - Link to register: https://events.teams.microsoft.com/event/b153afca-2aee-44e1-a0c1-046bd01a5dc2@1bf6ea47-c80c-40c7-ab4e-7c53dee6c46b
📩 For more information, contact Alexandre Morizot at amorizot@cqdm.org
Or visit : https://arenapole.ca/financement-innovation-arn-en-entreprise/
